Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Should Medicare Value-Based Purchasing Take Social Risk into Account?

Joynt KE, De Lew N, Sheingold SH, Conway PH, Goodrich K, Epstein AM.

N Engl J Med. 2017 Feb 9;376(6):510-513. doi: 10.1056/NEJMp1616278. Epub 2016 Dec 28. No abstract available.

2.

The Hospital Readmissions Reduction Program.

Zuckerman RB, Sheingold SH, Epstein AM.

N Engl J Med. 2016 Aug 4;375(5):494. doi: 10.1056/NEJMc1606658. No abstract available.

3.

Hospice Use, Hospitalization, and Medicare Spending at the End of Life.

Zuckerman R, Stearns S, Sheingold S.

J Gerontol B Psychol Sci Soc Sci. 2016 May 10. pii: gbw053. [Epub ahead of print] No abstract available.

PMID:
27166124
4.

Readmissions, Observation, and the Hospital Readmissions Reduction Program.

Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM.

N Engl J Med. 2016 Apr 21;374(16):1543-51. doi: 10.1056/NEJMsa1513024. Epub 2016 Feb 24.

5.

Understanding Medicare Hospital Readmission Rates And Differing Penalties Between Safety-Net And Other Hospitals.

Sheingold SH, Zuckerman R, Shartzer A.

Health Aff (Millwood). 2016 Jan;35(1):124-31. doi: 10.1377/hlthaff.2015.0534.

PMID:
26733710
6.

Hospice Use, Hospitalization, and Medicare Spending at the End of Life.

Zuckerman RB, Stearns SC, Sheingold SH.

J Gerontol B Psychol Sci Soc Sci. 2016 May;71(3):569-80. doi: 10.1093/geronb/gbv109. Epub 2015 Dec 11.

PMID:
26655645
7.

Executive Function, Survival, and Hospitalization in Chronic Obstructive Pulmonary Disease. A Longitudinal Analysis of the National Emphysema Treatment Trial (NETT).

Dodd JW, Novotny P, Sciurba FC, Benzo RP; NETT Research Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1473-81. doi: 10.1513/AnnalsATS.201506-373OC.

8.

Medicare's hospice benefit: analysis of utilization and resource use.

Bogasky S, Sheingold S, Stearns SC.

Medicare Medicaid Res Rev. 2014 Jul 29;4(2). pii: mmrr2014-004-02-b03. doi: 10.5600/mmrr.004.02.b03. eCollection 2014.

9.

Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit.

Sheingold S, Nguyen NX.

Medicare Medicaid Res Rev. 2014 Jan 2;4(1). pii: mmrr.004.01.a01. doi: 10.5600/mmrr.004.01.a01. eCollection 2014.

10.

Explaining variation in hospice visit intensity for routine home care.

Stearns SC, Sheingold S, Zuckerman RB.

Med Care. 2014 Jan;52(1):56-62. doi: 10.1097/MLR.0000000000000009.

PMID:
24220685
11.

Using a social capital framework to enhance measurement of the nursing work environment.

Sheingold BH, Sheingold SH.

J Nurs Manag. 2013 Jul;21(5):790-801. doi: 10.1111/jonm.12127.

PMID:
23865931
12.

Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease.

Benzo R, Siemion W, Novotny P, Sternberg A, Kaplan RM, Ries A, Wise R, Martinez F, Utz J, Sciurba F; National Emphysema Treatment Trial Research Group.

J Pain Symptom Manage. 2013 Oct;46(4):491-499.e4. doi: 10.1016/j.jpainsymman.2012.10.283. Epub 2013 Mar 21.

13.

Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency.

Kim V, Kretschman DM, Sternberg AL, DeCamp MM Jr, Criner GJ; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1109-16. doi: 10.1164/rccm.201203-0538OC. Epub 2012 Aug 9.

14.

Indirect medical education and disproportionate share adjustments to Medicare inpatient payment rates.

Nguyen NX, Sheingold SH.

Medicare Medicaid Res Rev. 2011 Nov 4;1(4). doi: 10.5600/mmrr.001.04.a01.

15.

Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.

Come CE, Divo MJ, San José Estépar R, Sciurba FC, Criner GJ, Marchetti N, Scharf SM, Mosenifar Z, Make BJ, Keller CA, Minai OA, Martinez FJ, Han MK, Reilly JJ, Celli BR, Washko GR; NETT Research Group.

Respir Med. 2012 Jan;106(1):109-19. doi: 10.1016/j.rmed.2011.07.012. Epub 2011 Aug 16.

16.

The minimal important difference of exercise tests in severe COPD.

Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F; National Emphysema Treatment Trial (NETT) Research Group.

Eur Respir J. 2011 Apr;37(4):784-90. doi: 10.1183/09031936.00063810. Epub 2010 Aug 6.

17.

Perfusion scintigraphy and patient selection for lung volume reduction surgery.

Chandra D, Lipson DA, Hoffman EA, Hansen-Flaschen J, Sciurba FC, Decamp MM, Reilly JJ, Washko GR; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2010 Oct 1;182(7):937-46. doi: 10.1164/rccm.201001-0043OC. Epub 2010 Jun 10.

18.

Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.

Giardino ND, Curtis JL, Andrei AC, Fan VS, Benditt JO, Lyubkin M, Naunheim K, Criner G, Make B, Wise RA, Murray SK, Fishman AP, Sciurba FC, Liberzon I, Martinez FJ; NETT Research Group.

Respir Res. 2010 Mar 9;11:29. doi: 10.1186/1465-9921-11-29.

19.

Physiological and computed tomographic predictors of outcome from lung volume reduction surgery.

Washko GR, Martinez FJ, Hoffman EA, Loring SH, Estépar RS, Diaz AA, Sciurba FC, Silverman EK, Han MK, Decamp M, Reilly JJ; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2010 Mar 1;181(5):494-500. doi: 10.1164/rccm.200906-0911OC. Epub 2009 Dec 3.

20.

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.

Han MK, Wise R, Mumford J, Sciurba F, Criner GJ, Curtis JL, Murray S, Sternberg A, Weinman G, Kazerooni E, Fishman AP, Make B, Hoffman EA, Mosenifar Z, Martinez FJ; NETT Research Group.

Eur Respir J. 2010 May;35(5):1048-56. doi: 10.1183/09031936.00052509. Epub 2009 Nov 19.

Supplemental Content

Loading ...
Support Center